← All trials
NCT01672736
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2012
- Primary completion
- Dec 1, 2017
- Completion date
- Dec 1, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 75
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- University of TorontoLead sponsor
- Multiple Myeloma Research ConsortiumCollaborator
- AstellasCollaborator
- University of TorontoOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.